Educating future leaders in cancer research and care. Follow to discover programs for all training levels from high school to undergrad/grad through faculty.
Joined April 2018
- Tweets 455
- Following 1,044
- Followers 616
- Likes 2,917
86 Photos and videos
UCSD Health Moores Cancer Center CRCERA retweeted
30 Dec 2022
Rana R. McKay, MD, of @UCSDCRCERA, discusses key clinical trials that have shifted the treatment paradigms in metastatic castration-resistant prostate cancer, nonmetastatic castration-resistant prostate cancer, and advanced prostate cancer. #pcsm ow.ly/x1Mv50MbIXP
1
245
UCSD Health Moores Cancer Center CRCERA retweeted
13 Jul 2022
Blocking tumour protein FAK releases checkpoint brake making #ovariancancer susceptible to #immunotherapy. Image and research by @DOzmadenci et al @UCSDCancer @UCSD_ObGyn @UCSDCRCERA in @PNASNews. Read more on bpod.mrc.ac.uk/archive/2022/… with @MRC_LMS and @AntDLewis
2
7
UCSD Health Moores Cancer Center CRCERA retweeted
3 Jul 2022
Jennifer M. Matro, MD, of @UCSDCRCERA, provides an in-depth look at clinical trials that have added to the breast cancer paradigm and how she is interpreting the findings for clinical practice #bcsm ow.ly/s5Jb50JMNix
1
UCSD Health Moores Cancer Center CRCERA retweeted
2 Jul 2022
Sandip P. Patel, MD, of @UCSDCRCERA, discusses frontline immunotherapy in advanced NSCLC, the treatment of patients with EGFR- and KRAS G12C–mutant and EGFR exon 20 insertion–positive disease, and the management of stage III disease #lcsm ow.ly/Cp3s50JMN1W
1
UCSD Health Moores Cancer Center CRCERA retweeted
21 Jun 2022
Jennifer M. Matro, MD, of @UCSDCRCERA, provides an in-depth look at clinical trials that have added to the breast cancer paradigm and how she is interpreting the findings for clinical practice #bcsm ow.ly/g9t050JBBps
2
UCSD Health Moores Cancer Center CRCERA retweeted
19 Jun 2022
Sandip P. Patel, MD, of @UCSDCRCERA, frontline immunotherapy in advanced NSCLC, the treatment of patients with EGFR- and KRAS G12C–mutant and EGFR exon 20 insertion–positive disease, and the management of stage III disease #lcsm ow.ly/AnkP50JAx9x
3
2
UCSD Health Moores Cancer Center CRCERA retweeted
10 Jun 2022
Thomas Kipps, MD, PhD, of @UCSDCRCERA, discusses navigating treatment regimens in CLL and MCL, the success of brentuximab vedotin in Hodgkin lymphoma, choosing between TKIs in CML, and the importance of transfusion independence in MDS #lymsm #leusm ow.ly/uj5M50IKQCY
2
UCSD Health Moores Cancer Center CRCERA retweeted
10 Jun 2022
Sandip P. Patel, MD, of @UCSDCRCERA, frontline immunotherapy in advanced NSCLC, the treatment of patients with EGFR- and KRAS G12C–mutant and EGFR exon 20 insertion–positive disease, and the management of stage III disease #lcsm ow.ly/eesZ50Iz8bl
1
UCSD Health Moores Cancer Center CRCERA retweeted
11 Jun 2022
Jennifer M. Matro, MD, of @UCSDCRCERA, provides an in-depth look at clinical trials that have added to the breast cancer paradigm and how she is interpreting the findings for clinical practice #bcsm ow.ly/AXY750Iz8le
1
1
UCSD Health Moores Cancer Center CRCERA retweeted
2 Jun 2022
HOLD THE DATE: September 9, 2022 33rd Annual Mahajani Symposium focusing on TUMOR DORMANCY. Amazing line up including @GhajarLab @lab_gomes @luciaborriell @Giancotti_Lab @megeblad @JF_CoteLab @alvarezlabhutch and Kay Yeung. Co-hosted by @salkinstitute @UCSDCRCERA @SBPCancerCenter
1
7
17
UCSD Health Moores Cancer Center CRCERA retweeted
7 Jun 2022
Benjamin Heyman, MD, of @UCSDCRCERA, discusses the phase 3 SYMPATICO trial examining the combination of ibrutinib and venetoclax vs ibrutinib alone in patients with relapsed or refractory mantle cell lymphoma #lymsm bit.ly/3tk0h5v
2
1
UCSD Health Moores Cancer Center CRCERA retweeted
25 May 2022
Sandip P. Patel, MD, of @UCSDCRCERA, discusses frontline immunotherapy in advanced NSCLC, the treatment of patients with EGFR- and KRAS G12C–mutant and EGFR exon 20 insertion–positive disease, and the management of stage III disease #lcsm ow.ly/6hOs50Jfl6f
1
UCSD Health Moores Cancer Center CRCERA retweeted
23 May 2022
Please see select Gastrointestinal Stromal Tumor (#GIST) #Sarcoma abstracts presented at @ASCO #ASCO22 @ConquerCancerFd @ASCOPost by @SteveBialickDO @SylvesterCancer @pawel_sobczuk @MSCActions @VHIO @im_schaefer @DanaFarber @JasonSicklick @UCSDCRCERA
15
41
UCSD Health Moores Cancer Center CRCERA retweeted
15 Apr 2022
Join us on April 20 for the #LungCancerSeries webinar on Management of Patients with #ALK #Mutated #NSCLC. With Moderator @HatimHusainMD and panelists @oncoOuLungCA and @JoelNealMD Free registration visit: events.r20.constantcontact.c…
2
2
UCSD Health Moores Cancer Center CRCERA retweeted
15 Apr 2022
Thomas Kipps, MD, PhD, of @UCSDCRCERA discusses navigating treatment regimens in CLL and MCL, the success of brentuximab vedotin in Hodgkin lymphoma, choosing between TKIs in CML, and the importance of transfusion independence in MDS #lymsm #leusm ow.ly/uj5M50IKQCY
2
UCSD Health Moores Cancer Center CRCERA retweeted
9 Apr 2022
You can still support cancer research and donate to our Pharm team UCSD!
Link to click: support.curebound.org/team/3…
Thank you! @SilvioGutkind @PedalSD
4 Feb 2022
Pharm Team UCSD photo from 2019, before the COVID-19 pandemic.
Alexandra Newton, Ph.D., Distinguished Professor and J. Silvio Gutkind, Ph.D., Distinguished Professor and Chair with family and colleagues. @NewtonLab @CellSignalingSD @SilvioGutkind
2
7
UCSD Health Moores Cancer Center CRCERA retweeted
10 Apr 2022
Benjamin Heyman, MD, of @UCSDCRCERA, discusses future therapeutic directions in mantle cell lymphoma #lymsm ow.ly/Tsch50IFFx0
2
UCSD Health Moores Cancer Center CRCERA retweeted
9 Apr 2022
ARE YOU READY????
Let's go! Ride/run/walk/spin
Over $15 million raised to date to fund 78 innovative research grants in all types of cancer.
@PedalSD @sbpdiscovery @radychildrens @scrippsresearch @UCSDCRCERA @ljiresearch
support.curebound.org/give/3…
2
2
16
Calling all physicians, scientists, nurses, public health experts interested in cancer: register now for the inaugural Moores Cancer Center Oncology CME event! #Cancer #CancerResearch #oncology #CME @UCSanDiegoDRM @UCSDPharm @UCSDHealth @UCSDHealthAging
crcera.ucsd.edu/delivering-d…
12
15